RA

Reshma Ashish Khemka

Active Director Director DIN 01421931
DIN 01421931 First appointment Feb 2006 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 1 historical roles
Total affiliations 5 Since Feb 2006
Shareholding value •••• Premium profile

About Reshma Ashish Khemka

Data last updated:

Reshma Ashish Khemka is a Director at Amn Life Science Private Limited (since 2006), Director at Shreerama Tradeven Private Limited (since 2015) and Designated Partner at Dove Life Science Llp (since 2015), and holds 1 more current directorship. The companies operate in Pharma, Business Services and Real Estate and Construction. The 3 current companies with reported revenue have a combined latest revenue of ₹415 Cr; the largest is Amn Life Science Private Limited at ₹273 Cr (FY 2025). Earlier, Reshma Ashish Khemka was a Director at Amn Life Private Limited (from 2020).

DIN 01421931
Primary Designation Director
Industry Pharma
First Appointment 06 Feb 2006
Oldest Company Age 23 yrs
Largest company Amn Life Science Private Limited · ₹273 Cr (FY 2025)
Combined revenue ₹415 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Amn Life Science Private Limited U24230MH2003PTC140663
Director06 Feb 20062003₹273 Cr (FY 2025)Active
Shreerama Tradeven Private Limited U74999MH2015PTC271180
Director21 Dec 20152015₹142 Cr (FY 2024)Active
Designated Partner29 Dec 20152015₹43.5 Lakh (FY 2023)Active
Designated Partner19 Oct 20162016Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Amn Life Private Limited U24100MH2020PTC343922
Director17 Aug 20202020₹46.30 Cr (FY 2023)Amalgamated

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Reshma Ashish Khemka

NameDINCompanyDesignation
Ashish Vijay Khemka00757815Amn Life Science Private Limited , Shreerama Tradeven Private Limited and 2 moreManaging Director

Directorship timeline

Open interactive timeline →
Amn Life Private Limited
Amn Life Science Private Limited
Shreerama Tradeven Private Limited
Dove Life Science Llp
Premium access

Shareholding and investment profile for Reshma Ashish Khemka

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Reshma Ashish Khemka

Reshma Ashish Khemka currently holds 4 directorships: Amn Life Science Private Limited (Director, since 06 Feb 2006, revenue ₹273 Cr (FY 2025)); Shreerama Tradeven Private Limited (Director, since 21 Dec 2015, revenue ₹142 Cr (FY 2024)); Dove Life Science Llp (Designated Partner, since 29 Dec 2015, revenue ₹43.5 Lakh (FY 2023)); Siaram Trading Llp (Designated Partner, since 19 Oct 2016).

Reshma Ashish Khemka was first appointed on 06 Feb 2006 as Director at Amn Life Science Private Limited. The most recent appointment on record is 17 Aug 2020 at Amn Life Private Limited.

The 3 current companies of Reshma Ashish Khemka that report revenue have a combined latest revenue of ₹415 Cr: Amn Life Science Private Limited ₹273 Cr (FY 2025); Shreerama Tradeven Private Limited ₹142 Cr (FY 2024); Dove Life Science Llp ₹43.5 Lakh (FY 2023).

Reshma Ashish Khemka held 1 earlier board appointment: Amn Life Private Limited (Director, from 17 Aug 2020).

The current boards of Reshma Ashish Khemka's companies include Ashish Vijay Khemka (Amn Life Science Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available